News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Mergers and Acquisitions
PCI Significantly Expands Global Clinical Services Business Through Biotec Acquisition 9/19/2014
Allozyne, Inc. Sold For Scrap As MedImmune (AZN) Snaps Up Rights 9/19/2014
Cambridge Healthtech Institute & Knowledge Foundation Acquire The International Battery Seminar & Exhibition 9/18/2014
Denovo Biopharma Acquires Late-Stage Oncology Drug From Eli Lilly and Company (LLY) For Development As A Personalized Medicine 9/17/2014
QLT Inc. (QLTI) Provides Update On Merger With Auxilium Pharmaceuticals (AUXL) 9/17/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buys Rights To Tildrakizumab From Merck & Co. (MRK) For An Upfront Payment Of $80 Million 9/17/2014
Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants? 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Salix Pharmaceuticals, Ltd. (SLXP) Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal 9/17/2014
Google Inc. Dives Deeper Into Biotech With Lift Labs Acquisition 9/15/2014
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014
More Than 35% Of Allergan Inc. (AGN) Investors Demand Special Meeting; Support For Valeant Pharmaceuticals International (VRX) Merger Grows 9/12/2014
Sanofi (France) (SAN.PA) Aims For M&A With Genzyme Corporation (GENZ) 9/12/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
Mergers Hamper Innovation, Ex-Pfizer (PFE) Top Exec Says 9/11/2014
VWR International, LLC Expands European Tissue Diagnostics Portfolio With Acquisition Of Klinipath BV 9/10/2014
Kolltan Pharmaceuticals Inc. Acquires Xetrios Therapeutics And Exclusive Rights To Salk Institute for Biological Studies Patents Related To The TAM Receptor Tyrosine Kinase Family 9/10/2014
Mylan Inc. (MYL) Scoops Up Injectable Arixtra For $300 Million From Aspen Global Inc. 9/10/2014
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires The Ownership Of Three Soft Gel ANDA's From Par Pharmaceutical, Inc. 9/9/2014
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Jazz Pharmaceuticals plc (JAZZ) Stock Up On Allergan Inc. (AGN) Rumor 9/9/2014
Momenta Pharmaceuticals, Inc. (MNTA) Exercises Option To Acquire Novel Antibodies From AnaptysBio, Inc. 9/8/2014
Neos Therapeutics Acquires All Commercialization And Profit Rights To Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) From Chiesi USA And Coating Place, Inc. 9/8/2014
Envision Pharmaceutical Completes Its Acquisition Of Medtrak Services 9/8/2014
Medican Moves Toward Closing The Purchase Of 51 Percent Of International Herbs Medical Marijuana Ltd. (IHMML) 9/8/2014
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014
WellSpring Pharmaceutical Corporation Acquires BONINE®, An Over-The-Counter Drug For Motion Sickness, From Prestige Brands, Inc. 9/5/2014
DPT Laboratories, Ltd. Acquires Meda Pharmaceuticals’ Lakewood, New Jersey, Location 9/4/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
PPD, Inc. (PPDI) Acquires RCT Logic’s Exclusive License To Patented Clinical Trial Design Technology 9/3/2014
Albemarle Corporation (ALB) Completes Sale Of Antioxidant, Ibuprofen And Propofol Businesses To SI Group 9/3/2014
Eisai Inc. (ESALF.PK) Sells U.S. Rights To Zonegran® (zonisamide) Capsules To Concordia Pharmaceuticals 9/3/2014
MWI Veterinary Supply Acquires Vetspace 9/3/2014
Mercachem To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD) 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/28/2014
Tau Therapeutics, LLC And Xdynia Merge To Form Cavion 8/28/2014
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech (RHHBY) 8/28/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
DPx Holdings B.V. Reaches Definitive Agreement To Acquire Gallus Biopharmaceuticals, LLC 8/27/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
Roper Industries Announces Two Medical Acquisitions 8/27/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
VIVUS, Inc. (VVUS) Snags A Group Of Topiramate Patents From Johnson & Johnson (JNJ) 8/26/2014
Cannabis Science Inc. In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada 8/26/2014
Janssen Pharmaceutical Inc. Affiliate Cilag GmbH International Acquires Covagen AG 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Omnicell Closes Acquisition Of UK-Based Surgichem Limited And Updates 2014 Guidance 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Clinigen Group Further Strengthens Oncology Support Portfolio With Acquisition Of Ethyol® (Amifostine), From AstraZeneca PLC (AZN) 8/20/2014
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET® Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid 8/20/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE) 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Pharming Group (PHGUF.PK) Acquires New Product Leads Through The Acquisition Of Certain Assets Of TRM SASU For € 0.5 Million In Cash 8/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces Early Termination Of HSR Waiting Period For Pending Transaction 8/19/2014
GTCR Completes Acquisition Of Cole-Parmer Instrument Company 8/18/2014
Valeant Pharmaceuticals International (VRX) Extends Offer To Acquire Allergan Inc. (AGN) 8/18/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
SEC Investigating Valeant Pharmaceuticals International (VRX), Pershing Square's Hostile Takeover Bid For Allergan Inc. (AGN) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Allergan Inc. (AGN) Grabs TARIS Biomedical's Lead Program In Deal Worth $587.5 Million 8/14/2014
Mallinckrodt And Questcor Pharmaceuticals, Inc. (QCOR) Shareholders Approve Mallinckrodt's Acquisition Of Questcor 8/14/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
Valeant Pharmaceuticals International (VRX) Receives FTC Second Request Under Hart-Scott-Rodino 8/13/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014
Oncothyreon Inc. (ONTY) Announces Acquisition Of Alpine Biosciences 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
DRI Capital Pays Rush University Medical Center $42 Million For AMPYRA® Royalty Rights 8/12/2014
Allergan Inc. (AGN) Receives Second Request From Federal Trade Commission Regarding Valeant Pharmaceuticals International (VRX)’s Unsolicited Acquisition Proposal 8/11/2014
NextSourceCS Acquires Amatheon Compounding Services In An Effort To Help Alleviate The Absence Of Critical Discontinued Drugs In The Veterinary Industry 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Sterigenics International, Inc. Completes $826 Million Acquisition Of Nordion Inc. 8/6/2014
Alvogen Pays $187 Million For Korea's Dream Pharma 8/6/2014
The Cooper Companies, Inc. (COO) Completes Acquisition Of Sauflon Pharmaceuticals Inc. And Announces $700 Million 3-Year Term Loan 8/6/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
CIRCADIAN® Acquires A Controlling Stake In ZircLight Inc. With A Series A Investment Led By Ams AG 8/5/2014
The HallStar Company Expands Organics Portfolio With Florasolvs® Natural Esters Acquisition 8/5/2014
Stem Cell Company ReproCELL (Japan) Acquires 3D Cell Culture Company Reinnervate Limited (UK) And Human Tissue Supplier Bioserve (USA) 8/5/2014
Merck & Co., Inc. (MRK) Completes Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 8/5/2014
Cellular Biomedicine Group (CBMG) Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent 8/4/2014
ANI Pharmaceuticals, Inc. Acquires Vancocin® Capsules And Additional Vancomycin Assets From Shire 8/4/2014
PCI Announces Completion Of Penn Pharmaceutical Services Purchase 8/4/2014
Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Vote FOR Mallinckrodt's Acquisition Of Questcor 8/4/2014
Nordion Receives Investment Canada Act Approval And Announces Expected Closing Date For Acquisition By Sterigenics 8/4/2014
Closing For Pernix Therapeutics, Inc. (PTX) Transaction To Acquire Treximet® Tablets For Migraine From GlaxoSmithKline (GSK) Delayed 8/4/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses 8/1/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million 8/1/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Tigermed And Frontage Laboratories Complete Strategic Investment Agreement 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
Jin-En International Group Holding Co. Acquires Nascent Biotech Inc. And Changes Name To Nascent Biotech Inc. 7/29/2014
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX) 7/28/2014
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment 7/28/2014
PaxVax, Inc. Acquires FDA-Approved Typhoid Vaccine Vivotif 7/28/2014
Variation Biotechnologies Inc. And Paulson Capital Announce Completion Of Merger 7/28/2014
Rumor: Hospira, Inc. May Buy Danone's Medical-Nutrition Unit For $5 Billion 7/28/2014
PCI Expands Service Offering With Acquisition Of Penn Pharmaceutical Services 7/28/2014
Endo International plc (ENDP) Completes Acquisition Of Grupo Farmaceutico Somar® 7/25/2014
Simulations Plus (SLP) Provides Additional Details Regarding Cognigen Corporation Acquisition 7/25/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
WIRB-Copernicus Group Announces Acquisition Of Alliance Biosciences; Executives Join WCG Biosafety Division 7/24/2014
Simulations Plus (SLP) To Acquire Cognigen Corporation 7/24/2014
Chromatin, Inc. Acquires Sorghum Production And Supply Company, Production Seeds Plus, Inc. 7/23/2014
Waters Corporation (WAT) Acquires REIMS Technology, Strengthens Health Science Initiative 7/23/2014
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition 7/23/2014
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million 7/22/2014
Teva Pharmaceutical Industries Limited (TEVA) Completes Acquisition Of Labrys: Opens Door To A Strong And Novel Migraine Prevention And Treatment Franchise Within Its CNS Portfolio 7/21/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
ABL, Inc. Acquires Majority Interest In Platine Pharma Services 7/21/2014
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Gentiva Health Services (GTIV) Grabs $634 Million Bid, Rejects Kindred Bio (KIN)'s Stake Offer 7/18/2014
Symplmed Completes Ownership Of Perindopril Franchise With Acquisition Of ACEON® 7/18/2014
Perrigo Co. (PRGO) Mum On Published Merger Rumors, Potential Target For Abbott Laboratories (ABT) 7/17/2014
Pfizer Inc. (PFE) Snags INNOPHARMA In $360 Million Deal 7/17/2014
Thermo Fisher Scientific (TMO) To Sell Cole-Parmer Instrument Company For $480 Million 7/17/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Investor Believes Roche (RHHBY) May Buy Exelixis, Inc. (EXEL) For Skin Cancer Drug 7/16/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Shire Ready To Bow To AbbVie (ABBV)'s Increased $53 Billion Offer 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly and Company (LLY) 7/15/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
EPIRUS Biopharmaceuticals And Zalicus Inc. (ZLCS) Complete Merger - Combined Company Will Trade As EPIRUS Biopharmaceuticals 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Abbott Laboratories (ABT) Unloads Developed Markets Generics Unit To Mylan Inc. (MYL) For $5.3 Billion 7/14/2014
Ventrus Biosciences, Inc.  (VTUS) Becomes Assembly Biosciences As Stockholders Approve Merger With Assembly Pharmaceuticals 7/14/2014
ATS Labs, Inc. Announces the Acquisition Of MicroTest Labs, Inc. 7/14/2014
Lake Consumer Products Acquires License To Bring vH Essentials PMS Relief Product To Market 7/11/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Baxter International, Inc. (BAX) Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount 7/9/2014
NeoGenomics, Inc. (NGNM.OB) Completes Acquisition Of Path Logic 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
StoneCalibre Acquires Nucleic Acid Purification Products Manufacturer Edge BioSystems, Inc. 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Easton Pharmaceuticals (OP: EAPH) Announces Closing Of Agreement To Invest And Acquire Ownership Interest In AMFIL Technologies Inc. And The mPACT -GROzone Antimicrobial Systems Line Of Products 7/8/2014
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation  (SYK)'s BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis 7/8/2014
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014
AbbVie (ABBV) To Dispatch Research Chief Jim Sullivan To London 7/7/2014
Merus Labs International Inc. Agrees To Buy Dacha Strategic Metals Inc. 7/7/2014
Hospira, Inc. Completes Acquisition Of Orchid Chemicals & Pharmaceuticals Ltd.'s Active Pharmaceutical Ingredient Manufacturing And R&D Facility 7/7/2014
Genentech (RHHBY) To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals 7/7/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Bio-Techne Snags Novus Biologicals For $60 Million Cash 7/3/2014
IMPAX Laboratories, Inc. (IPXL) Acquires Two Products From Actavis (ACT) 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
PAREXEL International (PRXL) Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Integrated DNA Technologies Acquires SURVEYOR® Nuclease Business From Transgenomic, Inc. (TBIO) 7/2/2014
Quintiles, Inc. (Q) Completes Acquisition Of Encore Health Resources 7/2/2014
Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger 7/2/2014
Intrexon Corporation To Acquire Trans Ova Genetics 7/2/2014
Massachusett's bluebird bio (BLUE) Snaps Up Pregenen For Up To $139.9 Million 7/2/2014
Bay Area's Transcept Pharmaceuticals, Inc. (TSPT) Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Transcept Stock Up +19.60% At Market Close (July 1, 2014) 7/1/2014
Johnson & Johnson (JNJ) Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 7/1/2014
Welichem Responds To Completion Of Take-Over Bid 7/1/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Forest 7/1/2014
Actavis (ACT) Completes Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014



//-->